Meanwhile, whereas gene expression systems for metabolic engineering have traditionally been static or externally tunable, an expanding toolbox of metabolite-responsive gene regulators coupled with deeper insights into metabolic bottlenecks have given rise to dynamic control over engineered pathways.
An extended definition of the term metabolic engineering is given and its successful use in the construction of biorecognition elements of sensors is demonstrated.
Moreover, these analyses allowed us to identify further candidate genes which might be used for metabolic engineering purposes given the importance of the TCA cycle during development and/or stress situations.
The present contribution provides a fresh perspective on an important topic in metabolic engineering, and gives practical guidelines and design principles for a priori selection of isotopic tracers for 13C-MFA studies.
To address current limitations of metabolic engineering, this article gives insights on recent systems metabolic engineering approaches based on functional tools and method such as genome reduction, amino acid sensors based on transcriptional regulators and riboswitches, CRISPR interference, small regulatory RNAs, DNA scaffolding, and optogenetic control, and discusses future prospects.
Herein, we argue that quantifying the performance of metabolic engineering strategies in a given metabolic network should rely on the maximum 'theoretically' possible product yield in the network, given by the optimal inter-conversion of metabolites by using any biochemically feasible reaction.
Thus, KAY is the maximum flux that can be redirected for a given metabolic engineering strategy without losing stability.
Metabolic engineering is the term giving a concept of alteration in metabolomics of any organism by regulating biosynthetic mechanism through reconstitution of changes at genetic level.
Due to the industrial importance of these pathways, much attention has been given to metabolic engineering strategies to enhance citrate metabolism and to direct it toward increased levels of particular end products, in particular diacetyl.
However, such metabolic engineering attempts have not been successful.
